U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C20H21NO
Molecular Weight 291.3868
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of BUTINOLINE

SMILES

OC(C#CCN1CCCC1)(C2=CC=CC=C2)C3=CC=CC=C3

InChI

InChIKey=LWPXJPFOEPMIRG-UHFFFAOYSA-N
InChI=1S/C20H21NO/c22-20(18-10-3-1-4-11-18,19-12-5-2-6-13-19)14-9-17-21-15-7-8-16-21/h1-6,10-13,22H,7-8,15-17H2

HIDE SMILES / InChI

Description

Butinoline (also known as azulone) was used as an antispasmodic drug to treat gastritis.

Approval Year

Unknown
139594
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Not Provided
504
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
[Treatment of gastritis; clinical observations of the effect of azulone].
1952 Jan 4
[Prophylaxis and therapy of radiodermatitis with azulone preparations].
1956
[Cytological studies in evaluation of the therapeutic efficacy of an azulene-containing preparation (azulone liquidum) in gastritis].
1959 Aug 22
Patents

Patents

US5843408
2

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Name Type Language
BUTINOLINE
INN   WHO-DD  
INN  
Official Name English
butinoline [INN]
Common Name English
Butinoline [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29704
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID3046295
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
FDA UNII
G216926E9T
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
ChEMBL
CHEMBL1442660
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
CAS
968-63-8
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
DRUG CENTRAL
448
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
WIKIPEDIA
BUTINOLINE
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
SMS_ID
100000088612
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
INN
1631
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
NCI_THESAURUS
C78064
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
EVMPD
SUB06020MIG
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
PUBCHEM
68943
Created by admin on Fri Dec 15 16:06:09 GMT 2023 , Edited by admin on Fri Dec 15 16:06:09 GMT 2023
PRIMARY
ACTIVE MOIETY
Structure of BUTINOLINE
SALT/SOLVATE (PARENT)
Structure of BUTINOLINE PHOSPHATE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966